GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial (GMALLregistry)

Goethe University

Status: Enrolling

Conditions: Non-Hodgkin's Lymphoma; Acute Lymphoblastic Leukemia; Leukemia

Study type: Observational

Funder types: Other

Identifiers

NCT02872987

GMALL_Registry

Details and patient eligibility

About

The GMALL registry serves the purpose of ALL research and quality assurance. The Registry collects data about diagnostics, treatment and outcome of Adult ALL Patients in the clinical routine, whether or not the patient is treated within a clinical trial.

Enrollment: 10,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Acute Lymphoblastic Leukemia (All Subtypes) if treated according to ALL protocols
• Other Types of Leukemia (NK Cell Lymphoma/Leukemia, Biphenotypic Acute Leukemia) if treated according to ALL protocols
• Non-Hodgkin's Lymphoma of Following Subtypes: Burkitt Lymphoma, B Cell Lymphoma, B- or T-lineage Lymphoblastic Lymphoma, Anaplastic Large Cell Lymphoma, Other NHL) if treated according to B-ALL protocols
• Age minimum 18 yrs

Trial design

10,000 participants in 2 patient groups

B-ALL/NHL

ALL/ Lymphoblastic Lymphoma (LBL)